ASENT2020 Annual Meeting Evaluation

Question Title

* 1. How would you rate the following items?

	Excellent	Very Good	Good	Fair	Poor
Overall experience at the conference	Overall experience at the conference Excellent	Overall experience at the conference Very Good	Overall experience at the conference Good	Overall experience at the conference Fair	Overall experience at the conference Poor
Relevance of content presented	Relevance of content presented Excellent	Relevance of content presented Very Good	Relevance of content presented Good	Relevance of content presented Fair	Relevance of content presented Poor
Opportunities for networking and information exchange	Opportunities for networking and information exchange Excellent	Opportunities for networking and information exchange Very Good	Opportunities for networking and information exchange Good	Opportunities for networking and information exchange Fair	Opportunities for networking and information exchange Poor
Quality of presentations	Quality of presentations Excellent	Quality of presentations Very Good	Quality of presentations Good	Quality of presentations Fair	Quality of presentations Poor
Registration process	Registration process Excellent	Registration process Very Good	Registration process Good	Registration process Fair	Registration process Poor
Interactions with staff	Interactions with staff Excellent	Interactions with staff Very Good	Interactions with staff Good	Interactions with staff Fair	Interactions with staff Poor
Conference venue/facilities	Conference venue/facilities Excellent	Conference venue/facilities Very Good	Conference venue/facilities Good	Conference venue/facilities Fair	Conference venue/facilities Poor
Dates of the conference (Mon-Thurs)	Dates of the conference (Mon-Thurs) Excellent	Dates of the conference (Mon-Thurs) Very Good	Dates of the conference (Mon-Thurs) Good	Dates of the conference (Mon-Thurs) Fair	Dates of the conference (Mon-Thurs) Poor
Quality of the social events	Quality of the social events Excellent	Quality of the social events Very Good	Quality of the social events Good	Quality of the social events Fair	Quality of the social events Poor

Question Title

* 2. How would you rate the following sessions?

	Excellent	Very Good	Good	Fair	Poor
Careers in Neuroscience Dinner	Careers in Neuroscience Dinner Excellent	Careers in Neuroscience Dinner Very Good	Careers in Neuroscience Dinner Good	Careers in Neuroscience Dinner Fair	Careers in Neuroscience Dinner Poor
President's Symposium: Commercialization Pathways for Academic Inventions	President's Symposium: Commercialization Pathways for Academic Inventions Excellent	President's Symposium: Commercialization Pathways for Academic Inventions Very Good	President's Symposium: Commercialization Pathways for Academic Inventions Good	President's Symposium: Commercialization Pathways for Academic Inventions Fair	President's Symposium: Commercialization Pathways for Academic Inventions Poor
SIG Discussion: The Role of Advocacy in Drug Discovery and Development	SIG Discussion: The Role of Advocacy in Drug Discovery and Development Excellent	SIG Discussion: The Role of Advocacy in Drug Discovery and Development Very Good	SIG Discussion: The Role of Advocacy in Drug Discovery and Development Good	SIG Discussion: The Role of Advocacy in Drug Discovery and Development Fair	SIG Discussion: The Role of Advocacy in Drug Discovery and Development Poor
SIG Discussion: Tech Transfer Across Academia and Industry	SIG Discussion: Tech Transfer Across Academia and Industry Excellent	SIG Discussion: Tech Transfer Across Academia and Industry Very Good	SIG Discussion: Tech Transfer Across Academia and Industry Good	SIG Discussion: Tech Transfer Across Academia and Industry Fair	SIG Discussion: Tech Transfer Across Academia and Industry Poor
Neuromodulation for Neuropsychiatric Disease	Neuromodulation for Neuropsychiatric Disease Excellent	Neuromodulation for Neuropsychiatric Disease Very Good	Neuromodulation for Neuropsychiatric Disease Good	Neuromodulation for Neuropsychiatric Disease Fair	Neuromodulation for Neuropsychiatric Disease Poor
Autophagy-Lysosome pathway in neurodegenerative diseases	Autophagy-Lysosome pathway in neurodegenerative diseases Excellent	Autophagy-Lysosome pathway in neurodegenerative diseases Very Good	Autophagy-Lysosome pathway in neurodegenerative diseases Good	Autophagy-Lysosome pathway in neurodegenerative diseases Fair	Autophagy-Lysosome pathway in neurodegenerative diseases Poor
Closing the loop in DBS	Closing the loop in DBS Excellent	Closing the loop in DBS Very Good	Closing the loop in DBS Good	Closing the loop in DBS Fair	Closing the loop in DBS Poor
Neuroinflammation in demyelinating and degenerative diseases	Neuroinflammation in demyelinating and degenerative diseases Excellent	Neuroinflammation in demyelinating and degenerative diseases Very Good	Neuroinflammation in demyelinating and degenerative diseases Good	Neuroinflammation in demyelinating and degenerative diseases Fair	Neuroinflammation in demyelinating and degenerative diseases Poor
Poster Reception: Tuesday	Poster Reception: Tuesday Excellent	Poster Reception: Tuesday Very Good	Poster Reception: Tuesday Good	Poster Reception: Tuesday Fair	Poster Reception: Tuesday Poor
Dinner Symposium: Featured Speaker Joe Moskal	Dinner Symposium: Featured Speaker Joe Moskal Excellent	Dinner Symposium: Featured Speaker Joe Moskal Very Good	Dinner Symposium: Featured Speaker Joe Moskal Good	Dinner Symposium: Featured Speaker Joe Moskal Fair	Dinner Symposium: Featured Speaker Joe Moskal Poor
Translational Neurocircuitry Biomarkers	Translational Neurocircuitry Biomarkers Excellent	Translational Neurocircuitry Biomarkers Very Good	Translational Neurocircuitry Biomarkers Good	Translational Neurocircuitry Biomarkers Fair	Translational Neurocircuitry Biomarkers Poor
Gene Therapies for Neurodegenerative Disease: Development and Regulatory	Gene Therapies for Neurodegenerative Disease: Development and Regulatory Excellent	Gene Therapies for Neurodegenerative Disease: Development and Regulatory Very Good	Gene Therapies for Neurodegenerative Disease: Development and Regulatory Good	Gene Therapies for Neurodegenerative Disease: Development and Regulatory Fair	Gene Therapies for Neurodegenerative Disease: Development and Regulatory Poor
Advocacy groups’ role in accelerating drug development	Advocacy groups’ role in accelerating drug development Excellent	Advocacy groups’ role in accelerating drug development Very Good	Advocacy groups’ role in accelerating drug development Good	Advocacy groups’ role in accelerating drug development Fair	Advocacy groups’ role in accelerating drug development Poor
LUNCH AND LEARN: Funding for CNS: Small Business Innovation Research (SBIR)	LUNCH AND LEARN: Funding for CNS: Small Business Innovation Research (SBIR) Excellent	LUNCH AND LEARN: Funding for CNS: Small Business Innovation Research (SBIR) Very Good	LUNCH AND LEARN: Funding for CNS: Small Business Innovation Research (SBIR) Good	LUNCH AND LEARN: Funding for CNS: Small Business Innovation Research (SBIR) Fair	LUNCH AND LEARN: Funding for CNS: Small Business Innovation Research (SBIR) Poor
LUNCH AND LEARN: Neurotherapeutics Topics Buzz: Meet the Guest Editors	LUNCH AND LEARN: Neurotherapeutics Topics Buzz: Meet the Guest Editors Excellent	LUNCH AND LEARN: Neurotherapeutics Topics Buzz: Meet the Guest Editors Very Good	LUNCH AND LEARN: Neurotherapeutics Topics Buzz: Meet the Guest Editors Good	LUNCH AND LEARN: Neurotherapeutics Topics Buzz: Meet the Guest Editors Fair	LUNCH AND LEARN: Neurotherapeutics Topics Buzz: Meet the Guest Editors Poor
ASENT PIPELINE PRESENTATIONS	ASENT PIPELINE PRESENTATIONS Excellent	ASENT PIPELINE PRESENTATIONS Very Good	ASENT PIPELINE PRESENTATIONS Good	ASENT PIPELINE PRESENTATIONS Fair	ASENT PIPELINE PRESENTATIONS Poor
Integration of Wearable Technologies in Neurotherapeutics	Integration of Wearable Technologies in Neurotherapeutics Excellent	Integration of Wearable Technologies in Neurotherapeutics Very Good	Integration of Wearable Technologies in Neurotherapeutics Good	Integration of Wearable Technologies in Neurotherapeutics Fair	Integration of Wearable Technologies in Neurotherapeutics Poor
Natural History in Neuroscience	Natural History in Neuroscience Excellent	Natural History in Neuroscience Very Good	Natural History in Neuroscience Good	Natural History in Neuroscience Fair	Natural History in Neuroscience Poor
Pipeline Session: Wednesday	Pipeline Session: Wednesday Excellent	Pipeline Session: Wednesday Very Good	Pipeline Session: Wednesday Good	Pipeline Session: Wednesday Fair	Pipeline Session: Wednesday Poor
Epilepsy Update: The Decade of the Epilepsy Orphans	Epilepsy Update: The Decade of the Epilepsy Orphans Excellent	Epilepsy Update: The Decade of the Epilepsy Orphans Very Good	Epilepsy Update: The Decade of the Epilepsy Orphans Good	Epilepsy Update: The Decade of the Epilepsy Orphans Fair	Epilepsy Update: The Decade of the Epilepsy Orphans Poor
Evolution of AAVs for Widespread Gene Delivery to the Central Nervous System	Evolution of AAVs for Widespread Gene Delivery to the Central Nervous System Excellent	Evolution of AAVs for Widespread Gene Delivery to the Central Nervous System Very Good	Evolution of AAVs for Widespread Gene Delivery to the Central Nervous System Good	Evolution of AAVs for Widespread Gene Delivery to the Central Nervous System Fair	Evolution of AAVs for Widespread Gene Delivery to the Central Nervous System Poor
Tremor the Most Common Movement Disorder: New Insights Gleaned: Pathophysiology,Genetics,Therapy	Tremor the Most Common Movement Disorder: New Insights Gleaned: Pathophysiology,Genetics,Therapy Excellent	Tremor the Most Common Movement Disorder: New Insights Gleaned: Pathophysiology,Genetics,Therapy Very Good	Tremor the Most Common Movement Disorder: New Insights Gleaned: Pathophysiology,Genetics,Therapy Good	Tremor the Most Common Movement Disorder: New Insights Gleaned: Pathophysiology,Genetics,Therapy Fair	Tremor the Most Common Movement Disorder: New Insights Gleaned: Pathophysiology,Genetics,Therapy Poor

Question Title

* 3. How likely is it that you would attend ASENT Annual Meeting next year?

Extremely Likely

Very Likely

Somewhat Likely

Unlikely

Very Unlikely

Definitely Not

Question Title

* 4. How likely is it that you would recommend the ASENT Annual Meeting to a colleague

Extremely Likely

Very Likely

Somewhat Likely

Unlikely

Very Unlikely

Definitely Not

Question Title

* 5. Check any of the following that would make the meeting more appealing to you in the future.

Exhibit Area

Product Theaters

Corporate Membership

Opportunity to connect with special interest groups or disease area at lunch

Opportunities for group meetings concurrent with ASENT

Ability to book space on site for industry meetings

Opportunity to join an industry roundtable

Other (please specify)

Question Title

* 6. What was most valuable about the 2020 Annual Meeting?

Question Title

* 7. Please answer the following

	Yes	No	Unsure
Would you consider submitting an abstract to a future ASENT Meeting?	Would you consider submitting an abstract to a future ASENT Meeting? Yes	Would you consider submitting an abstract to a future ASENT Meeting? No	Would you consider submitting an abstract to a future ASENT Meeting? Unsure
Would you consider encouraging a peer to submit an abstract to a future ASENT Meeting?	Would you consider encouraging a peer to submit an abstract to a future ASENT Meeting? Yes	Would you consider encouraging a peer to submit an abstract to a future ASENT Meeting? No	Would you consider encouraging a peer to submit an abstract to a future ASENT Meeting? Unsure
Would you consider participating as a pipeline presenter at a future ASENT meeting?	Would you consider participating as a pipeline presenter at a future ASENT meeting? Yes	Would you consider participating as a pipeline presenter at a future ASENT meeting? No	Would you consider participating as a pipeline presenter at a future ASENT meeting? Unsure
Are you an ASENT Member?	Are you an ASENT Member? Yes	Are you an ASENT Member? No	Are you an ASENT Member? Unsure
Would you consider becoming an ASENT Member as a result of this meeting?	Would you consider becoming an ASENT Member as a result of this meeting? Yes	Would you consider becoming an ASENT Member as a result of this meeting? No	Would you consider becoming an ASENT Member as a result of this meeting? Unsure
Would you consider encouraging a colleague to attend or join as a result of this meeting?	Would you consider encouraging a colleague to attend or join as a result of this meeting? Yes	Would you consider encouraging a colleague to attend or join as a result of this meeting? No	Would you consider encouraging a colleague to attend or join as a result of this meeting? Unsure
Would you consider participating on the Program Committee (must be ASENT Member)?	Would you consider participating on the Program Committee (must be ASENT Member)? Yes	Would you consider participating on the Program Committee (must be ASENT Member)? No	Would you consider participating on the Program Committee (must be ASENT Member)? Unsure

Other (please specify)

Question Title

* 8. What topic(s) would you like to see covered in the 2021 program: Include a full sentence description

Question Title

* 9. What could be changed to make the meeting more useful to you and your colleagues?

Question Title

* 10. Please share the following

Name

Company/Organization

Was this your first ASENT meeting

Would you come back next year if you schedule will allow?